Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1 ; volume:13 ; number:4 ; day:8 ; month:11 ; year:2010 ; pages:1-2 ; date:12.2010
Journal of the International AIDS Society / International AIDS Society ; 13, Heft 4 (8.11.2010), 1-2, 12.2010
- Creator
-
Maroldo, L.
- Contributor
-
Fredrick, LM
Robinson-Morgan, K.
Trinh, R.
Podsadecki, TJ
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-13-S4-P30
- URN
-
urn:nbn:de:1111-2016052057723
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maroldo, L.
- Fredrick, LM
- Robinson-Morgan, K.
- Trinh, R.
- Podsadecki, TJ
- SpringerLink (Online service)
Other Objects (12)
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Adherence, coping strategies and depression in highly antiretroviral-experienced patients
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
Dispositional optimism, perceived health competence and adherence in highly antiretroviral-experienced patients
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Adherence, coping strategies and depression in highly antiretroviral-experienced patients
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
Dispositional optimism, perceived health competence and adherence in highly antiretroviral-experienced patients
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Adherence, coping strategies and depression in highly antiretroviral-experienced patients
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients